NeoGenomics to Report Fourth Quarter and Full Year 2024 Financial Results on February 18, 2025
NeoGenomics (NASDAQ: NEO) announced it will release its fourth quarter and full year 2024 financial results before U.S. markets open on Tuesday, February 18, 2025. The company will host a conference call and webcast at 8:30 a.m. ET on the same day to discuss the results and recent highlights.
Investors can access the live webcast through the company's Investor Relations website at ir.neogenomics.com. For those joining by phone, the dial-in numbers are (888) 506-0062 (domestic) and (973) 528-0011 (international), with participant access code 167039. A replay of the webcast will be available shortly after the call.
NeoGenomics (NASDAQ: NEO) ha annunciato che pubblicherà i suoi risultati finanziari del quarto trimestre e dell'anno intero 2024 prima dell'apertura dei mercati americani martedì 18 febbraio 2025. L'azienda terrà una conferenza telefonica e un webcast alle 8:30 a.m. ET dello stesso giorno per discutere i risultati e i recenti eventi salienti.
Gli investitori possono accedere al webcast live attraverso il sito web delle Relazioni con gli Investitori dell'azienda all'indirizzo ir.neogenomics.com. Per coloro che partecipano telefonicamente, i numeri per la chiamata sono (888) 506-0062 (nazionale) e (973) 528-0011 (internazionale), con il codice di accesso per i partecipanti 167039. Un replay del webcast sarà disponibile poco dopo la chiamata.
NeoGenomics (NASDAQ: NEO) anunció que publicará sus resultados financieros del cuarto trimestre y del año completo 2024 antes de la apertura de los mercados en EE.UU. el martes 18 de febrero de 2025. La compañía llevará a cabo una conferencia telefónica y un webcast a las 8:30 a.m. ET el mismo día para discutir los resultados y los aspectos destacados recientes.
Los inversores pueden acceder al webcast en vivo a través del sitio web de Relaciones con Inversionistas de la compañía en ir.neogenomics.com. Para aquellos que se unan por teléfono, los números de acceso son (888) 506-0062 (nacional) y (973) 528-0011 (internacional), con el código de acceso para los participantes 167039. Una repetición del webcast estará disponible poco después de la llamada.
네오제노믹스(나스닥: NEO)는 2025년 2월 18일 화요일 미국 시장 개장 전에 2024년 4분기 및 연간 재무 실적을 발표할 것이라고 발표했습니다. 회사는 같은 날 오전 8:30 ET에 결과 및 최근 하이라이트를 논의하기 위해 전화 회의 및 웹캐스트를 진행합니다.
투자자들은 회사의 투자자 관계 웹사이트 ir.neogenomics.com를 통해 라이브 웹캐스트에 액세스할 수 있습니다. 전화로 참여하는 경우, 다이얼 인 번호는 (888) 506-0062(국내)와 (973) 528-0011(국제)이며, 참가자 접근 코드 167039가 있습니다. 웹캐스트의 재생본은 회의 후 곧 이용 가능할 것입니다.
NeoGenomics (NASDAQ: NEO) a annoncé qu'elle publiera ses résultats financiers du quatrième trimestre et de l'année 2024 avant l'ouverture des marchés américains le mardi 18 février 2025. La société organisera une conférence téléphonique et un webinaire à 8h30 ET le même jour pour discuter des résultats et des faits saillants récents.
Les investisseurs peuvent accéder au webinaire en direct via le site Web des Relations avec les investisseurs de la société à l'adresse ir.neogenomics.com. Pour ceux qui participent par téléphone, les numéros de composition sont (888) 506-0062 (national) et (973) 528-0011 (international), avec le code d'accès pour les participants 167039. Un replay du webinaire sera disponible peu après l'appel.
NeoGenomics (NASDAQ: NEO) gab bekannt, dass die Finanzergebnisse für das vierte Quartal und das gesamte Jahr 2024 vor der Eröffnung der US-Märkte am Dienstag, den 18. Februar 2025, veröffentlicht werden. Das Unternehmen wird am selben Tag um 8:30 Uhr ET eine Telefonkonferenz und einen Webcast abhalten, um die Ergebnisse und aktuelle Höhepunkte zu besprechen.
Investoren können über die Investor-Relations-Website des Unternehmens unter ir.neogenomics.com auf den Live-Webcast zugreifen. Für diejenigen, die per Telefon teilnehmen, sind die Einwahlnummern (888) 506-0062 (national) und (973) 528-0011 (international), mit dem Zugangscode für Teilnehmer 167039. Eine Wiederholung des Webcasts wird kurz nach dem Anruf verfügbar sein.
- None.
- None.
The live webcast may be accessed by visiting the Investor Relations section of our website at ir.neogenomics.com or by clicking here. The webcast will be archived and available for replay shortly after the conclusion of the call.
To access the live call via telephone, dial (888) 506-0062 (domestic) or (973) 528-0011 (international) at least five minutes prior to the call. The participant access code is 167039.
About NeoGenomics, Inc.
NeoGenomics, Inc. specializes in cancer genetics testing and information services, providing one of the most comprehensive oncology-focused testing menus in the world for physicians to help them diagnose and treat cancer. The Company's Pharma Services Division serves pharmaceutical clients in clinical trials and drug development.
Headquartered in
View source version on businesswire.com: https://www.businesswire.com/news/home/20250129573716/en/
Investor Contact
Kendra Sweeney
kendra.sweeney@neogenomics.com
Media Contact
Andrea Sampson
asampson@sampsonprgroup.com
Source: NeoGenomics, Inc.
FAQ
When will NeoGenomics (NEO) release Q4 and full-year 2024 earnings?
How can investors join NeoGenomics' Q4 2024 earnings call?
What time is NeoGenomics' Q4 2024 earnings call?
Will there be a replay available for NeoGenomics' Q4 2024 earnings call?
